Therefore, first of all, we investigated the nature of ameloblastomas using the classic and revised neuroendocrine markers, CD56, SYP, CgA, and INSM1, as well as the correlation between CLU and the expression of neuroendocrine markers. Here, SYP is linked to ameloblastoma.